150
Participants
Start Date
August 31, 2011
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Valsartan
week 1: 40/80/160 week 2-78: 80/160/320mg, oral, by mouth, once daily
amlodipine
added to valsartan after week 8 if the MSSBP and/or MSDBP was higher than 95th percentile for age, gender and height under the maintenance valsartan dose
Hydrochlorothiazide
added to valsartan after week 8 if the MSSBP and/or MSDBP was higher than 95th percentile for age, gender and height under the maintenance valsartan dose
Novartis Investigative Site, Manila
Novartis Investigative Site, Quezon City
Novartis Investigative Site, Quezon City
Novartis Investigative Site, Rostock
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bochum
Novartis Investigative Site, Homburg
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Singapore
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Timișoara
Novartis Investigative Site, Voronezh
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Tg. Mures
Novartis Investigative Site, Iași
Novartis Investigative Site, Bucaramanga
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Santiago de Cali
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Cottbus
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY